Gaudino Rossella, Garel Catherine, Czernichow Paul, Léger Juliane
Pediatric Endocrinology and Diabetes Unit, INSERM U 457, Hôpital Robert Debré, 75019 Paris, France.
Clin Endocrinol (Oxf). 2005 Apr;62(4):444-8. doi: 10.1111/j.1365-2265.2005.02239.x.
To determine the proportion of the various types of thyroid disorders among newborns detected by the neonatal TSH screening programme, with a normally located thyroid gland. Patients and methods Of the 882 575 infants screened in our centre between 1981 and 2002, 85 infants with a normally located gland had persistent elevation of serum TSH values (an incidence of 1/10 383). Six of these 85 patients were lost to follow-up and were therefore excluded from the study. During follow-up, patients were classified as having permanent or transient hypothyroidism.
Among the 79 patients included in the study, transient (n = 30, 38% of cases) and permanent (n = 49, 62% of cases) congenital hypothyroidism (CH) was demonstrated during the follow-up at the age of 0.7 +/- 0.6 years and 2.6 +/- 1.8 years (P < 0.0001), respectively. The proportion of premature births was significantly higher in the group with transient CH (57%) than in the group with permanent CH (2%) (P < 0.0001). A history of iatrogenic iodine overload was identified during the neonatal period in 69% of transient cases. Among permanent CH cases (n = 49), patients were classified as having a goitre (n = 27, 55% of cases), a normal sized and shaped thyroid gland (n = 14, 29% of cases) or a hypoplastic gland (n = 8, 16% of cases). The latter patients demonstrated global thyroid hypoplasia (n = 3), a right hemithyroid (n = 2), hypoplasia of the left lobe (n = 2), or asymmetry in the location of the two lobes (n = 1). Patients with a normal sized and shaped thyroid gland showed a significantly less severe form of hypothyroidism than those with a goitre or a hypoplastic thyroid gland (P < 0.0002). Among permanent CH cases, those with a goitre (n = 27) had an iodine organification defect (n = 10), Pendred syndrome (n = 1), a defect of thyroglobulin synthesis (n = 8), or a defect of sodium iodine symporter (n = 1), and in seven patients no aetiology could be determined. Among permanent cases with a normal sized and shaped thyroid gland (n = 14), a specific aetiology was found in only one patient (pseudohypoparathyroidism) and two patients had Down's syndrome. Among those with a globally hypoplastic gland, a TSH receptor gene mutation was found in two patients.
A precise description of the phenotype can enhance our understanding of various forms of neonatal hypothyroidism as well as their prevalence and management. It also helps to identify cases of congenital hypothyroidism of unknown aetiology, which will need to be investigated in collaboration with molecular biologists.
确定新生儿促甲状腺激素(TSH)筛查项目检测出的甲状腺位置正常的各类甲状腺疾病在新生儿中的比例。患者与方法:1981年至2002年在我们中心接受筛查的882575例婴儿中,85例甲状腺位置正常的婴儿血清TSH值持续升高(发病率为1/10383)。这85例患者中有6例失访,因此被排除在研究之外。在随访期间,患者被分类为患有永久性或暂时性甲状腺功能减退症。
在纳入研究的79例患者中,随访期间分别在0.7±0.6岁和2.6±1.8岁时证实存在暂时性(n = 30,占病例的38%)和永久性(n = 49,占病例的62%)先天性甲状腺功能减退症(CH)(P < 0.0001)。暂时性CH组的早产比例(57%)显著高于永久性CH组(2%)(P < 0.0001)。69%的暂时性病例在新生儿期有医源性碘过量病史。在永久性CH病例(n = 49)中,患者被分类为患有甲状腺肿(n = 27,占病例的55%)、甲状腺大小和形状正常(n = 14,占病例的29%)或甲状腺发育不全(n = 8,占病例的16%)。后一组患者表现为全甲状腺发育不全(n = 3)、右侧半甲状腺(n = 2)、左叶发育不全(n = 2)或两叶位置不对称(n = 1)。甲状腺大小和形状正常的患者甲状腺功能减退症的严重程度明显低于甲状腺肿或甲状腺发育不全的患者(P < 0.0002)。在永久性CH病例中,患有甲状腺肿的患者(n = 27)存在碘有机化缺陷(n = 10)、彭德莱综合征(n = 1)、甲状腺球蛋白合成缺陷(n = 8)或钠碘同向转运体缺陷(n = 1),7例患者病因无法确定。在甲状腺大小和形状正常的永久性病例(n = 14)中,仅1例患者发现特定病因(假性甲状旁腺功能减退症),2例患者患有唐氏综合征。在全甲状腺发育不全的患者中,2例患者发现促甲状腺激素受体基因突变。
对表型的精确描述可增进我们对各种形式的新生儿甲状腺功能减退症及其患病率和治疗的理解。它还有助于识别病因不明的先天性甲状腺功能减退症病例,这些病例需要与分子生物学家合作进行研究。